Skip to main content

Trilogy Capital Inc.

Position in MRK — Merck & Co., Inc.

CIK 1722512 IRVINE, CA

Position in MRK

as of Jun 30, 2026 · filed Jul 6, 2026
Position Value
$5,143,726
+$202,093 QoQ
Shares Held
40,029
-2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#1,030
of 3,769 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Trilogy Capital Inc. holds $25,279,882 across 7 Drug Manufacturers - General names. MRK ranks #4 (20.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRK
Merck & Co., Inc.
This page
40,029 $5,143,726

All Filings in MRK

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,143,726 40,029
2026-03-31 $4,941,633 41,081
2025-12-31 $4,656,176 44,235
2025-09-30 $3,630,643 43,258
2025-06-30 $3,525,073 44,531
2025-03-31 $953,879 10,627
2024-12-31 $1,011,612 10,169
2024-09-30 $1,366,921 12,037
2024-06-30 $1,518,035 12,262
2024-03-31 $778,768 5,902
2023-12-31 $304,165 2,790
2023-09-30 $242,241 2,353
2023-06-30 $385,287 3,339
2023-03-31 $293,742 2,761
2022-12-31 $663,702 5,982
2022-09-30 $314,165 3,648
2022-06-30 $318,456 3,493
2022-03-31 $263,216 3,208